Gingivitis

Gingivitis is an inflammatory condition of the gingiva that can progress through several distinct stages. Understanding these stages is crucial for dental professionals in diagnosing and managing periodontal disease effectively. This lecture will outline the four stages of gingivitis, highlighting the key pathological changes that occur at each stage.

I. Initial Lesion

• Characteristics:
  • Increased Permeability: The microvascular bed in the gingival tissues becomes more permeable, allowing for the passage of fluids and immune cells.
  • Increased GCF Flow: There is an increase in the flow of gingival crevicular fluid (GCF), which is indicative of inflammation and immune response.
  • PMN Cell Migration: The migration of polymorphonuclear leukocytes (PMNs) is facilitated by various adhesion molecules, including:
    • Intercellular Cell Adhesion Molecule 1 (ICAM-1)
    • E-selectin (ELAM-1) in the dentogingival vasculature.
• Clinical Implications: This stage marks the beginning of the inflammatory response, where the body attempts to combat the initial bacterial insult.

II. Early Lesion

• Characteristics:

  • Leukocyte Infiltration: There is significant infiltration of leukocytes, particularly lymphocytes, into the connective tissue of the junctional epithelium.
  • Fibroblast Degeneration: Several fibroblasts within the lesion exhibit signs of degeneration, indicating tissue damage.
  • Proliferation of Basal Cells: The basal cells of the junctional and sulcular epithelium begin to proliferate, which may be a response to the inflammatory process.

• Clinical Implications: This stage represents a transition from initial inflammation to more pronounced tissue changes, with the potential for further progression if not managed.

III. Established Lesion

• Characteristics:

  • Predominance of Plasma Cells and B Lymphocytes: There is a marked increase in plasma cells and B lymphocytes, indicating a more advanced immune response.
  • Increased Collagenolytic Activity: The activity of collagen-degrading enzymes increases, leading to the breakdown of collagen fibers in the connective tissue.
  • B Cell Subclasses: The B cells present in the established lesion are predominantly of the IgG1 and IgG3 subclasses, which are important for the immune response.

• Clinical Implications: This stage is characterized by chronic inflammation, and if left untreated, it can lead to further tissue destruction and the transition to advanced lesions.

IV. Advanced Lesion

• Characteristics:

  • Loss of Connective Tissue Attachment: There is significant loss of connective tissue attachment to the teeth, which can lead to periodontal pocket formation.
  • Alveolar Bone Loss: Extensive damage occurs to the alveolar bone, contributing to the overall loss of periodontal support.
  • Extensive Damage to Collagen Fibers: The collagen fibers in the gingival tissues are extensively damaged, further compromising the structural integrity of the gingiva.
  • Predominance of Plasma Cells: Plasma cells remain predominant, indicating ongoing immune activity and inflammation.

• Clinical Implications: This stage represents the transition from gingivitis to periodontitis, where irreversible damage can occur. Early intervention is critical to prevent further progression and loss of periodontal support.

Effects of Smoking on the Etiology and Pathogenesis of Periodontal Disease

Smoking is a significant risk factor for the development and progression of periodontal disease. It affects various aspects of periodontal health, including microbiology, immunology, and physiology. Understanding these effects is crucial for dental professionals in managing patients with periodontal disease, particularly those who smoke.

Etiologic Factors and the Impact of Smoking

1. Microbiology

   • Plaque Accumulation:
     • Smoking does not affect the rate of plaque accumulation on teeth. This means that smokers may have similar levels of plaque as non-smokers.
   • Colonization of Periodontal Pathogens:
     • Smoking increases the colonization of shallow periodontal pockets by periodontal pathogens. This can lead to an increased risk of periodontal disease.
     • There are higher levels of periodontal pathogens found in deep periodontal pockets among smokers, contributing to the severity of periodontal disease.

2. Immunology

   • Neutrophil Function:
     • Smoking alters neutrophil chemotaxis (the movement of neutrophils towards infection), phagocytosis (the process by which neutrophils engulf and destroy pathogens), and the oxidative burst (the rapid release of reactive oxygen species to kill bacteria).
   • Cytokine Levels:
     • Increased levels of pro-inflammatory cytokines such as Tumor Necrosis Factor-alpha (TNF-α) and Prostaglandin E2 (PGE2) are found in the gingival crevicular fluid (GCF) of smokers. These cytokines play a role in inflammation and tissue destruction.
   • Collagenase and Elastase Production:
     • There is an increase in neutrophil collagenase and elastase in GCF, which can contribute to the breakdown of connective tissue and exacerbate periodontal tissue destruction.
   • Monocyte Response:
     • Smoking enhances the production of PGE2 by monocytes in response to lipopolysaccharides (LPS), further promoting inflammation and tissue damage.

3. Physiology

   • Gingival Blood Vessels:
     • Smoking leads to a decrease in gingival blood vessels, which can impair the delivery of immune cells and nutrients to the periodontal tissues, exacerbating inflammation.
   • Gingival Crevicular Fluid (GCF) Flow:
     • There is a reduction in GCF flow and bleeding on probing, even in the presence of increased inflammation. This can mask the clinical signs of periodontal disease, making diagnosis more challenging.
   • Subgingival Temperature:
     • Smoking is associated with a decrease in subgingival temperature, which may affect the metabolic activity of periodontal pathogens.
   • Recovery from Local Anesthesia:
     • Smokers may require a longer time to recover from local anesthesia, which can complicate dental procedures and patient management.

Clinical Implications

1. Increased Risk of Periodontal Disease:

   • Smokers are at a higher risk for developing periodontal disease due to the combined effects of altered microbial colonization, impaired immune response, and physiological changes in the gingival tissues.

2. Challenges in Diagnosis:

   • The reduced bleeding on probing and altered GCF flow in smokers can lead to underdiagnosis or misdiagnosis of periodontal disease. Dental professionals must be vigilant in assessing periodontal health in smokers.

3. Treatment Considerations:

   • Smoking cessation should be a key component of periodontal treatment plans. Educating patients about the effects of smoking on periodontal health can motivate them to quit.
   • Treatment may need to be more aggressive in smokers due to the increased severity of periodontal disease and the altered healing response.

4. Monitoring and Maintenance:

   • Regular monitoring of periodontal health is essential for smokers, as they may experience more rapid disease progression. Tailored maintenance programs should be implemented to address their specific needs.

Progression from Gingivitis to Periodontitis

The transition from gingivitis to periodontitis is a critical process in periodontal disease progression. This lecture will outline the key stages involved in this progression, highlighting the changes in microbial composition, host response, and tissue alterations.

Pathway of Progression

1. Establishment and Maturation of Supragingival Plaque:

   • The process begins with the formation of supragingival plaque, which is evident in gingivitis.
   • As this plaque matures, it becomes more complex and can lead to changes in the surrounding tissues.

2. Migration of Periodontopathogenic Bacteria:

   • When the microbial load overwhelms the local host immune response, pathogenic bacteria migrate subgingivally (below the gum line).
   • This migration establishes a subgingival niche that is conducive to the growth of periodontopathogenic bacteria.

Initial Lesion

• Timeline:
  • The initial lesion, characterized by subclinical gingivitis, appears approximately 2 to 4 days after the colonization of the gingival sulcus by bacteria.
• Clinical Manifestations:
  • Vasculitis: Inflammation of blood vessels in the gingival tissue.
  • Exudation of Serous Fluid: Increased flow of gingival crevicular fluid (GCF) from the gingival sulcus.
  • Increased PMN Migration: Polymorphonuclear neutrophils (PMNs) migrate into the sulcus in response to the inflammatory process.
  • Alteration of Junctional Epithelium: Changes occur at the base of the pocket, affecting the integrity of the junctional epithelium.
  • Collagen Dissolution: Perivascular collagen begins to dissolve, contributing to tissue breakdown.

Early Lesion

• Timeline:
  • The early lesion forms within 4 to 7 days after the initial lesion due to the continued accumulation of bacterial plaque.
• Characteristics:
  • Leukocyte Accumulation: There is a significant increase in leukocytes at the site of acute inflammation, indicating an ongoing immune response.
  • Cytopathic Alterations: Resident fibroblasts undergo cytopathic changes, affecting their function and viability.
  • Collagen Loss: Increased collagen loss occurs within the marginal gingiva, contributing to tissue destruction.
  • Proliferation of Basal Cells: The basal cells of the junctional epithelium proliferate in response to the inflammatory environment.

Pathogens Implicated in Periodontal Diseases

Periodontal diseases are associated with a variety of pathogenic microorganisms. Below is a list of key pathogens implicated in different forms of periodontal disease, along with their associations:

General Pathogens Associated with Periodontal Diseases

• Actinobacillus actinomycetemcomitans:

  • Strongly associated with destructive periodontal disease.

• Porphyromonas gingivalis:

  • A member of the "black pigmented Bacteroides group" and a significant contributor to periodontal disease.

• Bacteroides forsythus:

  • Associated with chronic periodontitis.

• Spirochetes (Treponema denticola):

  • Implicated in various periodontal conditions.

• Prevotella intermedia/nigrescens:

  • Also belongs to the "black pigmented Bacteroides group" and is associated with several forms of periodontal disease.

• Fusobacterium nucleatum:

  • Plays a role in the progression of periodontal disease.

• Campylobacter rectus:

  • These organisms include members of the new genus Wolinella and are associated with periodontal disease.

Principal Bacteria Associated with Specific Periodontal Diseases

1. Adult Periodontitis:

   • Porphyromonas gingivalis
   • Prevotella intermedia
   • Bacteroides forsythus
   • Campylobacter rectus

2. Refractory Periodontitis:

   • Bacteroides forsythus
   • Porphyromonas gingivalis
   • Campylobacter rectus
   • Prevotella intermedia

3. Localized Juvenile Periodontitis (LJP):

   • Actinobacillus actinomycetemcomitans
   • Capnocytophaga

4. Periodontitis in Juvenile Diabetes:

   • Capnocytophaga
   • Actinobacillus actinomycetemcomitans

5. Pregnancy Gingivitis:

   • Prevotella intermedia

6. Acute Necrotizing Ulcerative Gingivitis (ANUG):

   • Prevotella intermedia
   • Intermediate-sized spirochetes

Periodontal Medicaments

Periodontal diseases often require adjunctive therapies to traditional mechanical treatments such as scaling and root planing. Various medicaments have been developed to enhance the healing process and control infection in periodontal tissues. This lecture will discuss several periodontal medicaments, their compositions, and their clinical applications.

1. Elyzol

• Composition:
  • Elyzol is an oil-based gel containing 25% metronidazole. It is formulated with glyceryl mono-oleate and sesame oil.
• Clinical Use:
  • Elyzol has been found to be equivalent to scaling and root planing in terms of effectiveness for treating periodontal disease.
  • However, no adjunctive effects beyond those achieved with mechanical debridement have been demonstrated.

2. Actisite

• Composition:

  • Actisite consists of tetracycline-containing fibers.
  • Each fiber has a diameter of 0.5 mm and contains 12.7 mg of tetracycline per 9 inches of fiber.

• Clinical Use:

  • The fibers are placed directly into periodontal pockets, where they release tetracycline over time, helping to reduce bacterial load and promote healing.

3. Arestin

• Composition:

  • Arestin contains minocycline, which is delivered as a biodegradable powder in a syringe.

• Clinical Use:

  • Arestin is indicated for the treatment of periodontal disease and is applied directly into periodontal pockets, where it provides localized antibiotic therapy.

4. Atridox

• Composition:

  • Atridox contains 10% doxycycline in a syringeable gel system that is biodegradable.

• Clinical Use:

  • The gel is injected into periodontal pockets, where it solidifies and releases doxycycline over time, aiding in the management of periodontal disease.

5. Dentamycin and Periocline

• Composition:

  • Both Dentamycin and Periocline contain 2% minocycline hydrochloride.

• Clinical Use:

  • These products are used similarly to other local delivery systems, providing localized antibiotic therapy to reduce bacterial infection in periodontal pockets.

6. Periochip

• Composition:

  • Periochip is a biodegradable chip that contains chlorhexidine.

• Clinical Use:

  • The chip is placed in the gingival crevice, where it releases chlorhexidine over time, providing antimicrobial action and helping to control periodontal disease.

Significant Immune Findings in Periodontal Diseases

Periodontal diseases are associated with various immune responses that can influence disease progression and severity. Understanding these immune findings is crucial for diagnosing and managing different forms of periodontal disease.

Immune Findings in Specific Periodontal Diseases

1. Acute Necrotizing Ulcerative Gingivitis (ANUG):

   • Findings:
     • PMN (Polymorphonuclear neutrophil) chemotactic defect: This defect impairs the ability of neutrophils to migrate to the site of infection, compromising the immune response.
     • Elevated antibody titres to Prevotella intermedia and intermediate-sized spirochetes: Indicates an immune response to specific pathogens associated with the disease.

2. Pregnancy Gingivitis:

   • Findings:
     • No significant immune findings reported: While pregnancy gingivitis is common, it does not show distinct immune abnormalities compared to other forms of periodontal disease.

3. Adult Periodontitis:

   • Findings:
     • Elevated antibody titres to Porphyromonas gingivalis and other periodontopathogens: Suggests a heightened immune response to these specific bacteria.
     • Occurrence of immune complexes in tissues: Indicates an immune reaction that may contribute to tissue damage.
     • Immediate hypersensitivity to gingival bacteria: Reflects an exaggerated immune response to bacterial antigens.
     • Cell-mediated immunity to gingival bacteria: Suggests involvement of T-cells in the immune response against periodontal pathogens.

4. Juvenile Periodontitis:

   • Localized Juvenile Periodontitis (LJP):
     • Findings:
       • PMN chemotactic defect and depressed phagocytosis: Impairs the ability of neutrophils to respond effectively to bacterial invasion.
       • Elevated antibody titres to Actinobacillus actinomycetemcomitans: Indicates an immune response to this specific pathogen.
   • Generalized Juvenile Periodontitis (GJP):
     • Findings:
       • PMN chemotactic defect and depressed phagocytosis: Similar to LJP, indicating a compromised immune response.
       • Elevated antibody titres to Porphyromonas gingivalis: Suggests an immune response to this pathogen.

5. Prepubertal Periodontitis:

   • Findings:
     • PMN chemotactic defect and depressed phagocytosis: Indicates impaired neutrophil function.
     • Elevated antibody titres to Actinobacillus actinomycetemcomitans: Suggests an immune response to this pathogen.

6. Rapid Periodontitis:

   • Findings:
     • Suppressed or enhanced PMN or monocyte chemotaxis: Indicates variability in immune response among individuals.
     • Elevated antibody titres to several gram-negative bacteria: Reflects an immune response to multiple pathogens.

7. Refractory Periodontitis:

   • Findings:
     • Reduced PMN chemotaxis: Indicates impaired neutrophil migration, which may contribute to disease persistence despite treatment.

8. Desquamative Gingivitis:

   • Findings:
     • Diagnostic or characteristic immunopathology in two-thirds of cases: Suggests an underlying immune mechanism.
     • Autoimmune etiology in cases resulting from pemphigus and pemphigoid: Indicates that some cases may be due to autoimmune processes affecting the gingival tissue.